-
Professor Bo Dai: Targeting PSMA—How Novel Radioligand Therapies Are Reshaping the Treatment Landscape for Prostate Cancer
01 Oncology Frontier – Urology Frontier: Could you share the current clinical application and research progress of PSMA-targeted radioligand therapy in prostate cancer? Professor Bo Dai: PSMA-targeted radioligand therapy has…
-
Professor Benkang Shi: From Open Surgery to Robotic Precision—The Ongoing Evolution of Prostate Cancer Surgery
01 Oncology Frontier – Urology Frontier: Could you share your perspective on the advantages and disadvantages of different surgical approaches—namely open surgery, laparoscopic surgery, and robot-assisted laparoscopic surgery—for radical prostatectomy?…
-
Professor Lu Yang Explores Latest Advances and Combination Strategies in AR-Targeted Therapy at the 2025 Pujiang Prostate Cancer Congress
On June 27, 2025, the Pujiang Prostate Cancer Academic Congress was held in Shanghai, in conjunction with the Annual Meeting of the Chinese Society of Clinical Oncology Prostate Cancer Committee (CSCO-PC), the Prostate Cancer Meeting of the CACA Genitourinary Oncology Committee (CACA-GO), and the Annual Meeting of the Chinese Prostate Cancer Consortium (CPCC). The event…
-
APACC 2025 Interview Highlight | Professor Joe Jarvis on Confronting the Global Burden of Advanced HIV Disease
At the Asia-Pacific AIDS & Co-Infections Conference (APACC 2025), Professor Joe Jarvis from the National Institute for Health and Care Research (NIHR) shared urgent perspectives on a critically underserved area—advanced…
-
APACC 2025 Interview Highlight | Dr. Junko Tanuma on HIV Control and Syphilis Resurgence
During the Asia-Pacific AIDS & Co-Infections Conference (APACC 2025) in Tokyo, we had the privilege of speaking with Conference Chair Dr. Junko Tanuma, Professor at the International University of Health…
-
APACC Global Perspective丨Professor Joe Jarvis: Challenges and Global Strategies in Advanced HIV Disease Management
IDF: You described individuals with advanced HIV infection as a ‘neglected disease group’ in your report. What evidence supports this characterization? Which critical findings in World Health Organisation (WHO) reports…
-
APACC Global Perspective丨Dr. Benjamin Bavinton: Innovation in HIV PrEP Service Models and Optimization of Promotion Strategies in the Asia-Pacific
IDF: Could you please give a brief overview of your research focus and current key projects? Dr. Bavinton: My name is Benjamin Bavinton, and I work at the Kirby Institute,…
-
APACC Chair Dr. Junko Tanuma: Tackling HIV Control and Syphilis Resurgence Through Global Collaboration
IDF: As the Conference Chair, could you highlight key agenda innovations? How will Japan facilitate multinational collaboration on HIV and co-infection management across the Asia-Pacific region? Dr. Tanuma: Firstly, I…
Connecting Medical Expertise through Media